Scholars Central

Conference abstractPublished 23 Nov 2012

Nanosponge: An innovative drug carrier system - a review

Authors: Mamidi Hemanth Kumar

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug targeting and enhancing the bioavailability of poorly water soluble drugs by an effective drug delivery system has been a dream for a long time. Designing of effective drug delivery system by using nanotechnology has gained importance in recent times. Nanosponge is one of such effective drug delivery system which overcome the problems of drug toxicity and poor bioavailability. Nanosponges are innovative carriers which are about a size of a virus with a 3-dimensional network or scaffold structure and a nanometric cavity size. These can act as the carriers for several hydrophilic and lipophilic drugs which have poor aqueous solubility. The backbone is a long length of polyester which is mixed in solution with small molecules called cross-linkers that act like tiny grappling hooks to fasten different parts of the polymer together. The net effect is to form spherically shaped particles filled with cavities where drug molecules can be stored. By the attachment of specific peptide linkers, nanosponges are targeted to specific sites in the body thus minimize the adverse effects and increase the efficiency of the drug. It holds a promising future in various pharmaceutical applications in the coming years like enhanced product performance and elegancy, extended release, reduced irritation, improved thermal, physical, and chemical stability of product. In this review, an attempt is made to summarize the methods of development, characterization, applications and future of this innovative carrier system.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Mamidi Hemanth Kumar”